Background
Apolizumab (Hu1D10) is a humanized monoclonal anti-Human leukocyte antigen-DR beta-chain antibody. Apolizumab can mediate apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro.• HLA common and well-documented alleles in China., PMID:30073798• Association of Human Leukocyte Antigen (HLA) class II (DRB1andDQB1) alleles and haplotypes with Rheumatoid Arthritis in Sudanese patients., PMID:37426636• Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorder., PMID:28562177• Association between human leukocyte antigen class II-DR-DQ and narcolepsy: a case control study., PMID:39150697• Human leukocyte antigen class II (DRB1 and DQB1) alleles and haplotypes frequencies in patients with pemphigus vulgaris among the Serbian population., PMID:27072514• Sarcoidosis and human leukocyte antigen class I and II genes: it takes two to tango?, PMID:15003948• Amino acid polymorphisms in human histocompatibility leukocyte antigen class II and proinsulin epitope have impacts on type 1 diabetes mellitus induced by immune-checkpoint inhibitors., PMID:37114039• A new strategy for systematically classifying HLA alleles into serological specificities., PMID:35538616• Diagnosis of sarcoidosis., PMID:18664976• Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis., PMID:15713222